Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489
- 1 January 1989
- journal article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 34 (1-6) , 431-434
- https://doi.org/10.1016/0022-4731(89)90122-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumorsCancer Chemotherapy and Pharmacology, 1989
- 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitorJournal of Steroid Biochemistry, 1988
- Differential Responses of Sex Steroid Target Tissues of Rats Treated with 4-Hydroxyandrostenedione*Endocrinology, 1988
- Endocrine properties of 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304), a new irreversible aromatase inhibitorJournal of Steroid Biochemistry, 1987
- Potential clinical role of new aromatase inhibitorsSteroids, 1987
- 4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancerSteroids, 1987
- Biological characterization of 10-(2-propynyl) estr-4-ene-3,17-dione (MDL 18,962), an enzyme-activated inhibitor of aromataseSteroids, 1987
- Effect of a new aromatase inhibitor (SH489) on the growth of rat mammary tumors induced by 7,12-dimethylbenz- [α]-anthracene (DMBA)Journal of Steroid Biochemistry, 1987
- Aromatase inhibitors and benign prostatic hyperplasiaJournal of Steroid Biochemistry, 1986
- Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivoSteroids, 1981